Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, A.
Right arrow Articles by Johns, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, A.
Right arrow Articles by Johns, E. J.
J Am Soc Nephrol 15:316-325, 2004
© 2004 American Society of Nephrology


BASIC SCIENCE

{beta}2-Adrenoceptor Activation Attenuates Endotoxin-Induced Acute Renal Failure

Akio Nakamura*, Akira Imaizumi*, Yukishige Yanagawa*, Takao Kohsaka{dagger} and Edward J. Johns{ddagger}

*Department of Pediatrics, Teikyo University School of Medicine, Tokyo, Japan; {dagger}Department of Immunology, National Children’s Medical Centre, Tokyo, Japan; and {ddagger}Department of Physiology, University College Cork, Cork, Ireland.

Correspondence to: Dr. Akio Nakamura, Department of Paediatrics, Teikyo University School of Medicine, 2–11–1 Kaga, Itabashi-ku, Tokyo 173, Japan. Phone: 03-3964-1211 ext. 1480; Fax: 03-3579-8212; E-mail: akio{at}med.teikyo-u.ac.jp

ABSTRACT. Abnormalities in the {beta}2-adrenergic control of organ function have been implicated in the pathogenesis of several disease states, such as septic shock. The objectives of the present study were to define the contribution of {beta}2-adrenoceptors ({beta}2-AR) to normal renal physiology and to investigate whether overexpression of renal {beta}2-AR might be potentially beneficial in preventing progressive renal damage associated with endotoxemia. Adenoviral transgenes containing the human {beta}2-AR (Adeno-{beta}2-AR) were constructed and delivered into the rat kidney by means of intraparenchymal injections. Administration of 109 total viral particles of Adeno-{beta}2-AR induced an approximately threefold increase in {beta}2-AR density in the renal tissue, which 2 wk after delivery, enhanced GFR and sodium reabsorption compared with control rats. The enhanced GFR was abolished by the addition of the {beta}2-AR antagonist, ICI 118,551. Administration of lipopolysaccharide (LPS) caused a reduction in GFR, {beta}2-AR density, and cAMP together with enhanced TNF-{alpha} mRNA in the kidney. In rats overexpressing {beta}2-AR, the reduction in baseline GFR and elevation of TNF-{alpha} mRNA and leukocyte infiltration into the kidney associated with the endotoxin were blocked. These findings suggested the possibility that a renal-specific overexpression of {beta}2-AR preserves basal renal function in response to a ligand-independent {beta}2-AR activation and that the delivery of Adeno-{beta}2-AR gene is a potential novel therapeutic strategy for treatment of acute renal failure associated with sepsis.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP